ABOUT CENCORA PHARMALEX
Beginning in January 2024, companies in the PharmaLex family started a journey of rebranding aligned with Cencora, our parent company and a leading global pharmaceutical solutions organization centered on improving lives around the world.
PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
View our content to discover how our expanded capabilities can help you – or contact a Cencora PharmaLex expert today with any questions.
CONTACT INFORMATION
Cencora PharmaLex
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
WEBINARS
-
Explore key steps for preparing your medicinal product for the European market, including insights on challenges, timelines, and a success story.
-
Explore applications and limitations for artificial intelligence (AI) in healthcare as decision-makers determine whether to adopt the software in their environments.
-
Discover key steps you can take to not just survive an inspection, but take the TMF Throne.
GET MORE DETAILS ON OUR SOLUTIONS
-
Increase TMF health and organizational efficiency through built-in TMF best practices, the industry’s only AI-assisted eTMF, a mobile app that classifies during scanning, and an embedded, configurable TMF Quality Review module. PhlexTMF software incorporates innovation based on real input from our worldwide customers to address the business challenges they face every day.
-
Phlexglobal provides a unique balance of document processing expertise, scalable global resources, and advanced technologies to ensure your documents are processed according to your timeframe and SOPs—regardless of your eTMF provider.
-
Enable busy study teams to assess, prevent, and manage risk across the entire TMF spectrum – improving inspection-readiness with less effort.
-
Introducing the TMF Health Score – an expert methodology that provides an “early warning system” to commonly overlooked issues that often lead to inspection findings.
-
Easily export your Trial Master File into a secure, searchable, long-term archive – remaining compliant with requirements for TMF document retention, while preserving audit information and data.
-
As the industry leader in Trial Master File best practices, Phlexglobal understands the reasons why some companies fail inspections and why others consistently do well. Customers place their trust in Phlexglobal because of our proven mastery over the TMF-related questions and challenges they face every day.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
WHITE PAPERS
-
Digital Innovation In Pharmacovigilance
Explore how AI can transform your pharmacovigilance efforts and enhance patient safety by leveraging the insights and decision framework outlined here.
-
Mastering The Complexities Of Targeted Medicines
Explore the challenges and strategies involved in developing targeted medicines, with insights into the complexities, collaborations, and considerations necessary for success.
-
20 Years Of Biosimilars: Are We On The Right Track?
Explore the transformative journey of biosimilars, 20 years in. Through industry expert insights collected from a recent panel discussion, explore regulatory hurdles, market shifts, and the path ahead.
PODCASTS
-
Exploring The Interactions Between Validation, Technology Transfer
Listen as Gerardo Gomez delves into the intricate relationship between validation and technology transfer, taking into account the perspectives and standards set by regulators.
-
Early Access Programs: What They Are And How To Plan For Them
Explore how early access programs are tailored to individual sufferers of rare, ultra-rare, or life-threatening conditions, as well as cohort programs, which target groups of patients afflicted with the same disease.
-
Navigating The Process Of Technology Transfer
Olena Chervonenko, Associate Director Quality Management and Compliance at PharmaLex, provides deeper insights into technology transfer and essential factors for achieving success.
E-BOOKS AND OTHER INSIGHTS
-
How Patient-Centric Approaches Are Shaping The Future Of CGT
Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.
-
A Comparative Guide To CGTs: Modalities, Landscape, And Logistics
Cell and gene therapies (CGTs) have the potential to revolutionize medicine. However, achieving therapeutic success requires advanced logistical consideration to ensure product safety and efficacy
-
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions
Explore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.